The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot ExperienceKai Ninomiya, Yoshinobu Onuma, Shinichiro Masuda et al.|Reviews in Cardiovascular Medicine|2022Cited by 5
TCT-937 Short-term and Long-term forecasting of clinical events in the Multivessel TALENT Trial with de novo three vessel coronary artery disease populationYoshinobu Onuma, Akihiro Tobe, Pruthvi C. Revaiah et al.|Journal of the American College of Cardiology|2025Cited by 0